Mastercard faces the possibility of a £14 billion (US$18.2 billion) lawsuit after the Court of Appeal in London made a surprise ruling. And nearly every British adult could get a payout of up to £300 (US$391), reported BBC.
That court stated that the Competition Appeal Tribunal (CAT) must reconsider the class action against the payments firm after it initially threw out that lawsuit two years ago.
The claim, which was brought on by the former financial ombudsman Walter Merricks, alleges that 46 million people unduly paid higher prices in shops due to high card fees. The class action was brought on behalf of people who were resident in the UK for at least three months between 1992 and 2008, were aged over 16, and who bought an item or service from a UK business which accepted Mastercard.
Mastercard said in a statement it continued to “disagree fundamentally with the basis of the claim” and added, “this decision is not a final ruling and the proposed claim is not approved to move forward; rather, the court has simply said a rehearing on certain issues should happen.” It also said it was seeking permission to appeal against the ruling.
Full Content: BBC, Payments Source
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Athletes File New Objections to NCAA’s $2.8 Billion Settlement Proposal
May 15, 2025 by
CPI
TikTok Charged by EU Over Alleged Breach of Digital Services Act
May 15, 2025 by
CPI
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas